# Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

> **NCT00299572** · PHASE4 · UNKNOWN · sponsor: **Far Eastern Memorial Hospital** · enrollment: 50 (—)

## Conditions studied

- Peritoneal Dialysis

## Interventions

- **DRUG:** alendronate (Fosamax)

## Key facts

- **NCT ID:** NCT00299572
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299572, "Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00299572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*